calendar

5 catalysts · 5 approval

next 91 dayslessmore

MonWedFri

view

sort

type

therapy area

no tagged catalysts yet

Week of Apr 1, 2019

›Apr 4, 2019approval2686d agoBUSULFAN — FDA approvalWoodward Pharma Services LLC

Sponsor: ACTAVIS. Form: INJECTABLE. Route: INJECTION

›Apr 4, 2019approval2686d agoBUSULFAN — FDA approvalWoodward Pharma Services LLC

Sponsor: ACTAVIS. Form: INJECTABLE. Route: INJECTION

›Apr 4, 2019approval2686d agoLOSARTAN POTASSIUM — FDA approvalLOSARTAN POTASSIUM

Sponsor: HETERO LABS LTD V. Form: TABLET. Route: ORAL

›Apr 4, 2019approval2686d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

›Apr 4, 2019approval2686d agoTREMFYA (GUSELKUMAB) — FDA approvalguselkumab

Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION